Structures by: Suresh D.
Total: 34
C35H35BN2
C35H35BN2
Dalton transactions (Cambridge, England : 2003) (2019) 48, 35 13337-13352
a=8.7182(8)Å b=17.212(2)Å c=18.794(2)Å
α=95.340(4)° β=99.889(4)° γ=90.231(4)°
C41H41BN2,0.5(C6H14)
C41H41BN2,0.5(C6H14)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 35 13337-13352
a=11.832(2)Å b=14.352(3)Å c=21.983(4)Å
α=90° β=103.421(7)° γ=90°
C37H27BN2
C37H27BN2
Dalton transactions (Cambridge, England : 2003) (2019) 48, 35 13337-13352
a=12.435(3)Å b=15.353(4)Å c=13.984(3)Å
α=90° β=91.186(9)° γ=90°
C41H88Cl2Cu4I4N14P4
C41H88Cl2Cu4I4N14P4
Dalton Transactions (2008) 25 3272-3274
a=10.2608(8)Å b=18.556(1)Å c=18.541(1)Å
α=68.787(1)° β=80.755(1)° γ=81.243(1)°
C56H90Cu4I4N14O4P4
C56H90Cu4I4N14O4P4
Dalton Transactions (2008) 25 3272-3274
a=22.928(1)Å b=14.8182(7)Å c=21.085(1)Å
α=90.00° β=90.00° γ=90.00°
C17H41IN4P2
C17H41IN4P2
Dalton Transactions (2008) 21 2812-2814
a=14.090(3)Å b=25.9449(18)Å c=27.452(3)Å
α=90.00° β=90.00° γ=90.00°
C62H39CuINO6P2S3
C62H39CuINO6P2S3
Dalton Transactions (2008) 17 2285-2292
a=14.799(1)Å b=16.396(1)Å c=22.002(2)Å
α=90.00° β=104.064(1)° γ=90.00°
C70H44CuI2.33N2O6P2S3
C70H44CuI2.33N2O6P2S3
Dalton Transactions (2008) 17 2285-2292
a=38.803(3)Å b=13.801(1)Å c=17.579(1)Å
α=90.00° β=90.00° γ=90.00°
C17H41AuClIN4P2
C17H41AuClIN4P2
Dalton Transactions (2008) 21 2812-2814
a=15.5625(7)Å b=11.9084(13)Å c=15.895(2)Å
α=90.00° β=118.376(3)° γ=90.00°
C27H21BN2
C27H21BN2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 39 15603-15620
a=8.9836(3)Å b=13.3666(4)Å c=17.2368(6)Å
α=90° β=94.218(2)° γ=90°
C33H33BN2
C33H33BN2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 39 15603-15620
a=10.6591(9)Å b=8.7127(7)Å c=14.2325(13)Å
α=90° β=90.856(5)° γ=90°
C35H25BN2
C35H25BN2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 39 15603-15620
a=12.2486(9)Å b=9.0701(7)Å c=21.8347(15)Å
α=90° β=91.772(4)° γ=90°
C23H16N2
C23H16N2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 39 15603-15620
a=26.1429(14)Å b=5.5789(3)Å c=22.5584(11)Å
α=90° β=102.477(2)° γ=90°
C21H24N2
C21H24N2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 39 15603-15620
a=9.1486(18)Å b=13.496(3)Å c=14.507(3)Å
α=90° β=97.345(6)° γ=90°
C23H19BN2
C23H19BN2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8502-8505
a=17.7637(16)Å b=11.2623(10)Å c=18.0062(15)Å
α=90.00° β=90.691(5)° γ=90.00°
C40H32B2N4,2(CH2Cl2)
C40H32B2N4,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 28 8502-8505
a=8.1967(3)Å b=11.7901(4)Å c=19.9616(6)Å
α=90.00° β=95.809(2)° γ=90.00°
C11H9N2Na
C11H9N2Na
Dalton transactions (Cambridge, England : 2003) (2010) 39, 3 736-748
a=10.1739(15)Å b=10.0052(14)Å c=19.371(3)Å
α=90.00° β=94.439(9)° γ=90.00°
C11H10N2
C11H10N2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 3 736-748
a=9.4490(14)Å b=18.186(3)Å c=21.204(3)Å
α=90.00° β=90.00° γ=90.00°
C11H10N2
C11H10N2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 3 736-748
a=12.0440(14)Å b=18.727(2)Å c=16.3890(18)Å
α=90.00° β=91.941(8)° γ=90.00°
C17H22N2
C17H22N2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 3 736-748
a=17.197(2)Å b=10.6030(11)Å c=17.6180(19)Å
α=90.00° β=108.648(6)° γ=90.00°
C42H62N4Na2O2
C42H62N4Na2O2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 3 736-748
a=11.704(6)Å b=10.390(4)Å c=17.231(7)Å
α=90.00° β=95.563(16)° γ=90.00°
4-[1,3-di-<i>tert</i>-butyl-4-(4,4-dimethylpiperazin-4-ium-1- yl)-2,4-diselanylidene-1,3,2λ^5^,4λ^5^-diazadiphosphedin-2- yl]-1,1-dimethylpiperazin-1-ium iodide hydrate
C20H47N6P2Se2,0.5(OH2),2I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=32.556(3)Å b=9.5372(10)Å c=21.679(2)Å
α=90° β=107.558(2)° γ=90°
1,3-Di-<i>tert</i>-butyl-2,4-bis-<i>tert</i>-butylamino- 2-methyl-4-selenoxo-4λ^5^-[1,3,2,4]diazadiphosphetidin- 2-ium iodide toluene solvate
C24H49N4P2Se,I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=9.3436(6)Å b=10.3905(7)Å c=16.7060(13)Å
α=93.176(1)° β=104.556(1)° γ=91.995(1)°
1,3-Di-<i>tert</i>-butyl-2,4-diselenoxy-2λ^5^,4λ^5^- [1,3,2,4]diazadiphosphetidin-2,4-di(yloxyethyl trimethylammonium) Iodode Hydrate
C18H44N4O2P2Se2,2(I),H2O
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=12.1752(9)Å b=14.2395(11)Å c=36.578(3)Å
α=90° β=94.6320(10)° γ=90°
Iodo(2,2-bipyridine-κN:κN')(1,3-di-<i>tert</i>- butyl-2,4-bis(<i>tert</i>-butylamino)-2-methyl-[1,3,2,4] diazadiphosphetidin-2-ium-κP)copper(I) Iodide
C27H49CuIN6P2,I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=14.1715(6)Å b=14.6142(6)Å c=16.8817(7)Å
α=90° β=90° γ=90°
Μ-Triiodobis(1,3-di(<i>tert</i>-butyl)-2,4-bis(<i>tert</i>- butylamino)-2-methyl-[1,3,2,4]diazadiphosphetidin- 2-ium)-κ-P dicopper(I) iodide acetonitrile solvate
C34H82Cu2I3N8P4,C2H3N,I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=10.3950(7)Å b=29.9149(18)Å c=17.8929(11)Å
α=90° β=95.847(1)° γ=90°
Iodo(1,10-phenanthroline-κN:κN)(1,3-di-<i>tert</i>- butyl-2,4-bis(<i>tert</i>-butylamino)-2-methyl-[1,3,2,4] diazadiphosphetidin-2-ium-κP)copper(I) Iodide
C29H49CuIN6P2,I
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=24.7202(11)Å b=10.1169(4)Å c=14.2381(6)Å
α=90° β=90° γ=90°
Chlorido{1,3-di-tert-butylbis(tert-butylamino)-2-methyl-1,3,2,4- diazadiphosphetidin-2-ium}gold(I) trifluoromethanesulfonate
C17H41AuClN4P2,CF3O3S
Dalton transactions (Cambridge, England : 2003) (2014) 43, 23 8835-8848
a=9.714(3)Å b=10.396(3)Å c=17.440(6)Å
α=81.865(4)° β=85.488(4)° γ=62.617(4)°
1,1'-thiobis(2-naphthol)
C20H14O2S
Acta Crystallographica Section C (2007) 63, 8 o487-o488
a=4.8053(6)Å b=11.4200(10)Å c=26.732(3)Å
α=90.00° β=93.181(2)° γ=90.00°
1,1'-thiobis(2-naphthol)
C20H14O2S
Acta Crystallographica Section C (2007) 63, 8 o487-o488
a=13.6508(9)Å b=5.2192(3)Å c=21.2650(10)Å
α=90.00° β=105.4090(10)° γ=90.00°
4-fluoro-<i>N</i>-(1<i>H</i>-pyrrol-2-ylmethylidene)aniline
C11H9FN2
Acta Crystallographica Section C (2011) 67, 8 o315-o318
a=9.5542(5)Å b=18.7198(9)Å c=21.1509(12)Å
α=90.00° β=90.00° γ=90.00°
2-[(1<i>H</i>-pyrrol-2-ylmethylidene)amino]benzonitrile
C12H9N3
Acta Crystallographica Section C (2011) 67, 8 o315-o318
a=12.5935(13)Å b=10.1843(11)Å c=16.901(2)Å
α=90.00° β=107.035(5)° γ=90.00°
(1,3-di(tert-butyl)-2,4-bis(N-morpholino)-2,4-bis[iodo (1,10-phenanthroline-κ^2^N,N)copper(I)][1,3,2,4] diazadiphosphetidine acetonotrile solvate
C40H50Cu2I2N8O2P2,C2H3N1
Inorganic Chemistry (2010) 49, 8790-8801
a=18.9807(7)Å b=10.1871(4)Å c=25.6733(9)Å
α=90.00° β=98.252(1)° γ=90.00°
1,3-Di(tert-butyl)-2,4-di(4-methylpiperazinyl)-2,4- bis(iodo(1,10-phenanthroline-κ^2^N,N)copper(I))- [1,3,2,4]-diazadiphosphetidine tetrahydrate acetonitrile solvate
C44H67Cu2I2N11O4P2
Inorganic Chemistry (2010) 49, 8790-8801
a=12.6096(9)Å b=14.843(1)Å c=14.939(1)Å
α=103.025(1)° β=92.238(1)° γ=107.422(1)°